Boston Startups

Commonwealth Fusion

Building the path to clean, carbon-free, limitless energy Sustainability Renewable Energies

Last round: Series B Khosla Ventures, $2B Series B in 2021

ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome. Biotech Healthcare Pharmaceuticals

Last round: Series B Andreessen Horowitz, $50M Series B in 2021, $70M valuation

Scipher Medicine

Scipher Medicine develops a healthcare platform designed to determine which drug will work best for each patient. Healthcare Biotech

Last round: Series D Khosla Ventures, $110M Series D in 2022

Biofourmis

Biofourmis is a biotechnology company that augments personalized care and therapies using digital therapeutics. Healthcare Biotech

Last round: Series C Sequoia, $100M Series C in 2020, $700M valuation

Silk

Silks optimizes the cloud, allowing organizations to get 10x the performance while spending 30% less SaaS Enterprise Software

Last round: Series B Sequoia, $55M Series B in 2021

Zus Health

Zus empowers an entirely new wave of healthcare builders to create technologies and services without the usual blockers Healthcare Medical Software

Last round: Series A Andreessen Horowitz, $40M Series A in 2023

Devoted Health

Devoted Health is a healthcare company serving seniors and giving them a health care plan with personal guides and world-class technology. Healthcare Elder Care

Last round: Series D Andreessen Horowitz, $362M Series D in 2021, $1.1B valuation

Starburst Data

Starburst Data is a data access and analytics company developing an SQL query engine. Software Analytics Data Science

Last round: Series D Andreessen Horowitz, $250M Series D in 2022, $3.4B valuation

Asimov

Asimov builds tools to program living cells. Biotech

Last round: Series B Andreessen Horowitz, $175M Series B in 2023

eGenesis

eGenesis is a life sciences company focused on development and commercialization of engineered organisms for the benefit of human health. Biotech

Last round: Series C Khosla Ventures, $125M Series C in 2021, $99M valuation

Digital.ai

Leading provider of software delivery automation for the enterprise. Enterprise Software Developer Tools

Last round: Series B Accel, $122M Series B in 2018

Dyno Therapeutics

Dyno Therapeutics uses artificial intelligence for gene therapy. Healthcare Biotech Artificial Intelligence

Last round: Series A Andreessen Horowitz, $100M Series A in 2021

CAMP4 Therapeutics

BioTech. Solving how genes are controlled to drive the efficient development of treatments. Biotech

Last round: Series B Andreessen Horowitz, $100M Series B in 2022

Devo

Devo is a cybersecurity company that provides cloud-native logging and security analytics for organizations. Cybersecurity Enterprise Software

Last round: Series F Bessemer, $100M Series F in 2022, $2.0B valuation

Fractyl Labs

Developing an Innovative Endoscopic Outpatient Procedure to Improve Glycemic Control for Type 2 Diabetes Healthcare Medical Devices

Last round: Series F Bessemer, $100M Series F in 2021

Emulate

Emulate is focused on commercializing Organs-on-Chips. Healthcare Biotech

Last round: Series E Founders Fund, $82M Series E in 2021